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Abstract
The urinary tract is frequently being exposed to potential pathogens and rapid defence mechanisms are therefore needed.
Cathelicidin, a human antimicrobial peptide is expressed and secreted by bladder epithelial cells and protects the urinary
tract from infection. Here we show that vitamin D can induce cathelicidin in the urinary bladder. We analyzed bladder tissue
from postmenopausal women for expression of cathelicidin, before and after a three-month period of supplementation
with 25-hydroxyvitamin D3 (25D3). Cell culture experiments were performed to elucidate the mechanisms for cathelicidin
induction. We observed that, vitamin D per se did not up-regulate cathelicidin in serum or in bladder tissue of the women in
this study. However, when the bladder biopsies were infected with uropathogenic E. coli (UPEC), a significant increase in
cathelicidin expression was observed after 25D3 supplementation. This observation was confirmed in human bladder cell
lines, even though here, cathelicidin induction occurred irrespectively of infection. Vitamin D treated bladder cells exerted
an increased antibacterial effect against UPEC and colocalization to cathelicidin indicated the relevance of this peptide. In
the light of the rapidly growing problem of resistance to common urinary tract antibiotics, we suggest that vitamin D may
be a potential complement in the prevention of UTI.
Citation: Hertting O, Holm A ˚,L u ¨thje P, Brauner H, Dyrdak R, et al. (2010) Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary
Bladder. PLoS ONE 5(12): e15580. doi:10.1371/journal.pone.0015580
Editor: Stefan Bereswill, Charite ´-University Medicine Berlin, Germany
Received October 20, 2010; Accepted November 12, 2010; Published December 14, 2010
Copyright:  2010 Hertting et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Swedish Research Council (no. 56X-20356), ALF Project Funding, and the Karolinska Institutet. O.H. has a
Karolinska Institutet funded postgraduate position. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Annelie.Brauner@ki.se
Introduction
Urinary tract infection (UTI) remains an important disease and
becomes more frequent in women after menopause. Due to the
proximity of the highly colonized perineum, the urinary tract
epithelium must be able to sense pathogens and elicit a fast innate
immune response in order to keep its integrity [1,2]. Previously we
demonstrated that the human antimicrobial peptide cathelicidin
was up-regulated upon E. coli infection and that it significantly
contributes to the protection of the urinary tract in humans and in
mice [3]. Here, we investigate vitamin D-induced boosting of
cathelicidin in the urinary bladder.
Vitamin D, apart from its well-known task to regulate calcium
metabolism, has been recognized to influence innate and acquired
immune reactions [4]. Skin exposure to sunlight and dietary intake
of fatty fish and dairy products are the predominant sources of
vitamin D [5]. In the liver, hydroxylation takes place and 25-
hydroxyvitamin D3 (25D3) is produced. The inactive form 25D3 is
converted in the kidney to its active metabolite 1,25D3 by the
hydroxylase CYP27B1 [6]. 1,25D3 binds to the vitamin D receptor
(VDR) and is transported into the nucleus where it acts as a
transcription factor. Recently, it has been shown that also non-
renal tissue can convert 25D3 to 1,25D3 [4]. Several studies have
concluded an intimate relationship between vitamin D and
cathelicidin production. Vitamin D can induce the human
cathelicidin gene (CAMP) expression by binding to the vitamin
D responsive element (VDRE) of the CAMP promoter [7,8] in
various tissues, e.g., keratinocytes [9], respiratory epithelium [10]
and monocytes [11]. Consequently, increased synthesis of
cathelicidin after vitamin D treatment has been observed.
We hypothesized that vitamin D could influence cathelicidin
production also in the urinary tract and thereby help protecting
from invading microbes. We show that urinary bladder cells
enhance cathelicidin production in response to vitamin D.
Moreover, we demonstrate the relevance of these findings in
bladder tissue from postmenopausal women receiving 25D3
supplementation. We also provide evidence that this increased
production has an antimicrobial effect. Our findings indicate that
25D3 may be a potential complement in the prevention of UTI.
Results
Postmenopausal women have low levels of serum
vitamin D which increase after 25D3 supplementation
After menopause, women have an increased risk of UTI,
coinciding with decreased vitamin D and estrogen levels. We
analysed 25D3 levels in serum from 22 Swedish healthy
postmenopausal and, for comparison, six premenopausal women.
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15580The median serum 25D3 values were 56 nmol/L and 74 nmol/L,
respectively (P,0.05). In the group of postmenopausal women,
only five women (23%) had 25D3 levels above the recommended
level of 75 nmol/L [12]. One was vitamin D deficient (,25 nmol/
L), nine were insufficient (,50 nmol/L) and the levels of the
remaining seven women were between 50 and 75 nmol/L
(Figure 1). Eight healthy postmenopausal women were later
recruited for vitamin D supplementation, with bladder biopsies
taken before and after the treatment period. Intake of 2000 units of
25D3 daily increased their median values of 25D3 in serum from
68.5 nmol/L to 104.5 nmol/L after 6 weeks (P,0.001) and
further to 117 nmol/L after 12 weeks (P,0.01, Figure 2A).
Notably, no correlation was seen between serum levels of 25D3
and cathelicidin in the serum before and after 6 or 12 weeks
treatment (Figure 2B). Calcium, phosphate and parathyroid
hormone were within the physiological range and not affected
by 25D3 treatment.
25D3 increases CAMP expression in E. coli-infected
urinary bladder epithelium
Vitamin D has been shown to activate the antimicrobial peptide
cathelicidin in a range of human cell types [13]. Therefore, we
investigated if this process also occurs in the urinary bladder.
Vitamin D treatment per se did not increase cathelicidin mRNA or
protein in bladder tissue, as determined by quantitative RT-PCR
and microscopy, respectively (data not shown). Bladder biopsies
taken before and after supplementation were also infected with E.
coli CFT073 ex vivo. After 25D3 supplementation, we found an
increase in CAMP expression upon infection compared to biopsies
priortosupplementation (P,0.05,Figure2C).Likewise,anincrease
incathelicidinproteinexpressionwasobserved(P,0.05,Figure1D).
Confocal microscope images showed that before 25D3 intake,
infection-induced cathelicidin production was restricted mainly to
the superficial umbrella cells (Figure 1E). After supplementation
however, more cathelicidin was produced and was also seen in cells
located deeper in the bladder epithelium (Figure 2F).
The converting enzyme CYP27B1 is present in the human
urinary bladder
To explain the effect of 25D3 on cathelicidin production in the
bladder of vitamin D-supplemented women, we hypothesized that
conversion of 25D3 to 1,25D3 takes place in the bladder
epithelium. Therefore we investigated whether CYP27B1, the
enzyme necessary for this conversion, is present in bladder
epithelial cells. Using RT-PCR, we found CYP27B1 mRNA in
normal human bladder cells and tissue, and in all three bladder
cell lines studied (Figure 3A). By immunofluorescence microscopy,
we could detect the presence of CYP27B1 in bladder tissue
sections (Figure 3B), localized throughout the cytoplasm with an
abundance of staining seen in the peri-nuclear area, consistent
with its association to mitochondria [14].
Inactive 25D3 is converted to active 1,25D3 in bladder
epithelial cells
Based on the findings that bladder epithelial cells are equipped
with the machinery for local 25D3 conversion, we investigated the
biological function of CYP27B1 in bladder epithelial cells. Normal
human bladder cells were exposed to 25D3 for 24 hours.
Conversion to active vitamin D was confirmed by the presence
of 1,25D3 in the cell culture supernatant at a concentration of
.0.4610
29 M. The concentration of 1,25D3 in culture medium
from untreated cells and 25D3 supplemented medium without cells
was below detection limit (,0.02610
29 M).
The vitamin D receptor is expressed in the urinary
bladder and in bladder epithelial cells
To up-regulate cathelicidin, active 1,25D3 binds to the VDR.
Thus, we investigated the presence of VDR in bladder epithelial
cells and bladder tissue from biopsies. Bladder cells and bladder
tissue expressed VDR mRNA constitutively, most abundantly in
normal human bladder cells and in cell line 5637 (Figure 3C).
VDR protein was detected in bladder epithelium by immunoflu-
orescence microscopy. On a cellular level, it was distributed both
in the cytoplasm and in the nucleus (Figure 3D).
The 1,25D3 metabolizing enzyme CYP24A1 is expressed
in the urinary bladder and in bladder epithelial cells
Since the 25-hydroxyvitamin D3 24-hydroxylase (CYP24A1) is
considered important in determining the biological half-life of
1,25D3 [15], we examined the expression of this enzyme in the
urinary bladder tissue and in the cell lines used in this study. Low
levels of gene-specific mRNA were detected in all cell lines
except for T24 cells, which expressed CYP24A1 at higher levels
(Figure 3E). Bladder tissue showed both mRNA and detectable but
low protein expression of CYP24A1 (Figure 3F).
1,25D3 and 25D3 enhance cathelicidin production
We further investigated the biological effect of 25D3 and 1,25D3
on vitamin D-dependent gene expression in bladder cells. As a
negative feedback regulator in vitamin D metabolism, the
hydroxylase CYP24A1 is strongly induced by 1,25D3 [15]. In
response to 1,25D3, expression of CYP24A1 was highly up-
regulated in normal bladder cells and TERT-NHUC (Figure 4A
and B). CYP24A1 up-regulation was also observed after incubation
with 25D3, indicating conversion of 25D3 to 1,25D3 (Figure 4A
and B). An up-regulation of CAMP in the presence of 1,25D3 or
25D3 was observed in all cell lines tested. Normal bladder cells
showed higher induction than TERT-NHUC bladder cells, 21-
fold and 5-fold respectively (Figure 4C and D). In the bladder
epithelial cell lines T24 and 5637, 1,25D3-mediated CAMP
induction was 16-fold and 140-fold, respectively (data not shown).
The expression of VDR was not influenced by 1,25D3 or 25D3
(Figure 4E–F). A small induction of CYP27B1 was observed in
TERT-NHUC bladder cells (Figure 4G).
Figure 1. Low levels of vitamin D3 in postmenopausal women.
Serum vitamin D3 levels in postmenopausal women are low compared
to premenopausal women, P,0.05 (Mann-Whitney test). Individual data
are presented with median levels (56 nmol/L and 74 nmol/L). The
recommended level of 75 nmol/L is marked with a dotted line.
doi:10.1371/journal.pone.0015580.g001
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increased protein production, immunofluorescence microscopy and
flow cytometry was performed. Cathelicidin levels increased
significantly in TERT-NHUC cells after 48 hours of 1,25D3 or
25D3 treatment (P,0.001, Figure 5A and B). Cells pre-treated with
vitamin D and infected with E. coli CFT073 expressed even higher
levels of cathelicidin (P,0.05 for 25D3 +/2 UPEC, Figure 5A and
B). Flow cytometry confirmed an increase of cathelicidin in 25D3
and 1,25D3 treated cells after E. coli infection (Figure 5C).
Vitamin D promotes cell-mediated killing of UPEC
Next, we investigated the biological effect of the increased
cathelicidin production in vitamin D-treated cells. We therefore
assessed the antibacterial properties of treated versus untreated cells
against UPEC strain CFT073. By confocal microscopy, we
visualized antibacterial activity on a cellular level. Killing of cell-
associated bacteria was demonstrated by Live/Dead staining
(Figure 6A). The significance of cathelicidin was demonstrated by
colocalization of cathelicidin with bacterial cells (Figure 6B). To
quantify antibacterial activity and the contribution of cathelicidin,
antibacterial assays in conditioned medium were performed.
Supernatant from bladder epithelial cells treated with 1,25D3
decreased growth of E. coli CFT073 by 44% in TERT-NHUC,
47% in T24, and by 23% in 5637 cells. Likewise, growth in cell
lysates was inhibited by 36% in 5637 and TERT-NHUC cells and
by 27% in T24 cells (Figure 6C). 1,25D3 in medium without cells
had no antibacterial effect (data not shown). In the presence of a
cathelicidin-neutralizing antibody, the antimicrobial effect of the
cell supernatant was significantly reduced, confirming the impact
of cathelicidin (Figure 6D).
Figure 2. 25D3 and cathelicidin in serum and bladder tissue of women during a three-month period of 25D3 supplementation.
Postmenopausal women were treated with 2000 units of oral 25D3 daily for 12 weeks. Serum samples were collected before, at 6 and 12 weeks.
Serum 25D3 levels increased from a baseline median value of 68.5 nmol/L to 104.5 nmol/L at 6 weeks, P,0.001 (Wilcoxon rank test), and 117 nmol/L
at 12 weeks, P,0.01 (Wilcoxon rank test). The dotted line denotes the recommended serum 25D3 level of 75 nmol/L and median values are indicated
(A). Despite treatment with 25D3, serum cathelicidin levels did not increase (B). E. coli-infected bladder biopsies from women receiving 25D3
supplementation responded with higher expression of CAMP mRNA, P,0.05 (Mann-Whitney test) (C) and cathelicidin protein, P ,0.05 (Mann-
Whitney test) (D) compared to infected pieces prior to supplementation. Fluorescence immunohistochemistry showed increased cathelicidin protein
expression in infected bladder biopsies. Tissue samples shown are from the same patient before (E) and after (F) 12 weeks of 25D3 treatment.
Cathelicidin is localized in the uroepithelium including the larger umbrella cells closest to the bladder lumen. Staining without primary antibody
serves as negative control (G). Images are captured at 663 magnification and depict an area corresponding to 1196119 mm. Cathelicidin is stained
with AlexaFluor 594 (red), the cell nucleus with DAPI (blue).
doi:10.1371/journal.pone.0015580.g002
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Here we show that oral 25D3 supplementation of healthy
postmenopausal women prepares the bladder tissue to fight E. coli
infection by increased production of cathelicidin upon bacterial
contact. 25D3 is locally converted to 1,25D3 in bladder epithelial
cells, binds to VDR, which leads to up-regulation of CAMP and
synthesis of cathelicidin. The increased production in turn
enhances the direct antibacterial effect on UPEC.
Women in menopause are prone to UTI. This is traditionally
mainly attributed to anatomical reasons and mucosal atrophy.
With age, VDR expression decreases [16] and there are reports
suggesting that women have lower vitamin D intake than men
[17]. The most important source of vitamin D is UVB-induced
photoactivation of previtamin D in the skin [18]. Because of its
geographical latitude, Sweden has only few hours of sunlight
during winter season. Hence, low levels of vitamin D in the study
population were anticipated. Still, it was surprising that 77% of
otherwise healthy postmenopausal women did not have sufficient
vitamin D levels. We therefore hypothesized that vitamin D may
be involved also in the defence against UTI, and that this is
mediated by cathelicidin.
The relatively high dose of 25D3 used in this study did not affect
constitutive cathelicidin production in the urinary bladder.
However, a local up-regulation was observed in the tissue in
response to infection with UPEC. Interestingly, 2000 units of 25D3
daily, about five times the recommended daily dose [19], showed
no increase in serum cathelidicin and did not influence serum
calcium levels. This is in line with previous reports showing no
correlation between high doses of vitamin D2 and circulating levels
of cathelicidin [20]. Thus, we speculate that 25D3 prepares the
cells to produce more cathelicidin only when needed to protect the
urinary tract from bacterial infection.
Vitamin D is a well-studied compound and currently supple-
mentation of 25D3 is being widely recommended [12]. Clinical
studies using 10 times the dose given in the present study reported
serum concentrations of 400 nmol/L with no hypercalcemia or
hypercalcuria [21]. The risk for unwanted side effects with the
Figure 3. Bladder epithelial cells are equipped with the machinery for local 25D3 conversion and activity. Expression of CYP27B1, VDR
and CYP24A1 was detected on mRNA level in normal bladder cells (HBEP) and three bladder cells lines (TERT-NHUC, 5637 and T24) by RT-PCR (A, C, E)
and on protein level in tissue from bladder biopsies by fluorescence immunohistochemistry (B, D, F). mRNA expression results were normalized to
expression in the kidney epithelial cell line A498. The proteins are stained with AlexaFluor 594 (red), the cell nucleus with DAPI (blue). CYP27B1
protein was detected in the bladder mucosa where it was evenly distributed in the bladder epithelial layers with an abundance of staining seen in the
peri-nuclear area, consistent with its association to mitochondria (B). VDR protein was localized in the cytoplasm and nucleus (D). Low levels of the
CYP24A1 protein were detected in bladder mucosa (F). All images are captured at663 magnification and the right panels of images B, D and F show
controls stained without primary antibodies against CYP27B1, VDR and CYP24A1, respectively.
doi:10.1371/journal.pone.0015580.g003
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successfully been used to enhance the immunity to pathogens in
the respiratory tract [22,23]. For this local protection to occur,
conversion of 25D3 to active 1,25D3 in peripheral tissue is needed.
Here, we localized the converting enzyme CYP27B1 in the
uroepithelium and in normal bladder cells. Activity of CYP27B1
was indicated by the detection of 1,25D3 in culture medium from
25D3 treated bladder cells, suggesting a local function of 1,25D3
within the bladder mucosa. We also confirm earlier studies
showing VDR expression in bladder tissue [24]. Normal bladder
cells and 5637 had the highest induction of CAMP, coinciding with
higher VDR levels. This raises the question if age-dependent loss
of VDR may lead to increased risk of UTI. The results from cell
lines differed from bladder tissue with respect to CYP27B1 and
CYP24A1. Thismaywellreflect thedifferencebetweena monolayer
of cells in culture and the complex nature of the multilayered
urothelium with cells at different level of differentiation.
Both 25D3 and 1,25D3 up-regulated cathelicidin production in
various bladder cell lines, and as a result, treated cells mediated
increased antibacterial activity. In the investigated cells, induction
was observed by vitamin D without additional stimuli. This is in
line with what previously has been demonstrated in respiratory
epithelial cells [25]. In contrast, in monocytes additional stimula-
tion via Toll-like receptor (TLR) is needed to induce cathelicidin
production [26]. We cannot rule out that our observed differences
in tissue versus cultured cells are due to lower concentrations of
25D3 and 1,25D3 in the target cells in vivo. It is plausible that, at
these concentrations, additional stimuli such as TLR signalling are
needed to induce detectable cathelicidin levels. On the other hand,
bacteria alone did not increase cathelicidin intracellularly under
the experimental conditions used here. This has previously been
observed for non-pathogenic E. coli and Neisseria; in contrast, even
a down-regulation was observed [27]. We believe that the
presence of vitamin D is sufficient and necessary to induce
cathelicidin, and might further be enhanced by the presence of
bacteria.
Our results suggest a role for vitamin D in the protection against
UTI. So far, no data are available on vitamin D levels and UTI
incidence. Still, there is an established link between vitamin D
deficiency and tuberculosis [28,29] and viral respiratory infections
[30,31]. Accordingly, low levels of VDR and VDR polymorphisms
have been associated with such infections in young children [32].
In light of the emerging resistance to antibiotics used against
UTI [33], new treatment strategies are needed. Our data suggest
that vitamin D can stimulate an increased production of the
antimicrobial peptide cathelicidin. By inducing and activating
cathelicidin with vitamin D, a local rather than a systemic effect
can be achieved. This could offer selective and site-specific
treatment of pathogens without perturbing commensal microbes
elsewhere in the body. Likewise, systemic effects of 25D3 treatment
secondary to cathelicidin induction seem unlikely. This could
make 25D3 an effective and safe way of activating the endogenous
antimicrobial response locally at the site of infection. Determining
the vitamin D status of individuals with a history of UTI may be of
Figure 4. Human bladder cells respond with CYP24A1 and CAMP induction to 1,25D3 and 25D3. Normal bladder cells (HBEP, upper panel)
and TERT-NHUC bladder cells (lower panel) were stimulated with 10
27 M 25D3 or 10
28 M 1,25D3 for 24 hours. Levels of gene-specific mRNA for
CYP24A1 (A, B), CAMP (C, D), VDR (E, F) and CYP27B1 (G, H) in stimulated cells were determined and are presented as fold change compared to
vector-treated control cells. Data presented are pooled from three independent experiments and shown as mean and standard deviation;
***P,0.001, **P,0.01, *P,0.05 (ANOVA with Dunnett’s post-test).
doi:10.1371/journal.pone.0015580.g004
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Supplementation to restore proper vitamin D levels may therefore
help preparing the bladder epithelium to mount a stronger and
faster immune response once bacteria enter the bladder.
Materials and Methods
Human participants
The study was approved by Regionala etikpro ¨vningsna ¨mnden
(EPN), Stockhom (The Regional Ethics Committe ´, Stockholm),
Protocol 2008/968-31. It was performed in accordance to the
Helsinki Declaration. Informed written consent was obtained from
volunteers involved in the study. Initially, 22 postmenopausal and
six premenopausal Swedish women of European descent (median
age 59) were analyzed regarding their serum vitamin D levels.
Eight additional women (median age 62) were later recruited to
receive daily oral supplementation with 2000 units of 25D3 (Recip,
Meda Pharmaceuticals) for 12 weeks. They had no history of
urinary tract abnormalities and none of the women received any
dietary supplements or hormonal treatment at the time of the
Figure 5. 1,25D3 or 25D3 in combination with E. coli increased cathelicidin protein in bladder epithelial cells. Production of cathelicidin
increased in TERT-NHUC bladder cells after treatment with 1,25D3 or 25D3, and was further increased by infection with E. coli CFT073 (UPEC). Images
are captured at663 magnification and depict an area corresponding to 1196119 mm( A). The control image (Neg control) is shown in the right upper
panel. Fluorescence intensity was quantified and is presented as mean values with standard deviation; ***P,0.001, *P,0.05 (ANOVA with Dunnett’s
post-test) (B). An increase in cathelicidin protein was also recorded by flow cytometry in E. coli-infected TERT-NHUC bladder cells treated with 1,25D3
or 25D3. Grey is vector +E. coli, red is 1,25D3 10
28 M+E. coli and black is 25D3 10
27 M+E. coli (C).
doi:10.1371/journal.pone.0015580.g005
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performed and superficial biopsies were taken from the urinary
bladder wall. After 12 weeks, follow-up biopsies were taken the
same way. Out of these eight women, five women underwent the
complete procedure. Serum samples were collected before as well
as 6 and 12 weeks after treatment and analyzed for 25D3,
cathelicidin, calcium, glucose, parathyroid hormone and phos-
phate. Urinalysis dipsticks (Nitristic, Raerad Products) were used
to rule out bacteriuria.
Measurement of 25D3 and 1,25D3
Serum samples were protected from light and stored at 280uC
prior to analysis. Total 25D3 analyses were performed using
LIASION 25-OH Vitamin D TOTAL kit, an antibody-based
chemiluminescence assay, detection limit 10 nmol/L (DiaSorin
Inc.). 1,25D3 in cell supernatants was determined with the
Gamma-B 1,25-dihydroxyvitamin D RIA kit, detection limit
0.02 nmol/L, cross-reactivity between 25D3 and 1,25D3 0.001%
(Immunodiagnostic Systems).
Measurement of serum cathelicidin
Cathelicidin in serum samples was measured using an enzyme-
linked immunosorbent assay (HyCult Technologies). After thaw-
ing, serum samples were diluted 20 times and assayed as
recommended by the manufacturer. Detection range was 0.14–
100 ng/L.
Figure 6. Vitamin D increases the cathelicidin-mediated antibacterial effect of bladder epithelial cells. Cell-associated UPEC are killed as
determined with Live/Dead staining where live bacteria are stained green and dead bacteria are stained red (A). UPEC attach and invade bladder cells
and are colocalized with cathelicidin. GFP-labelled E. coli CFT073 is green and cathelicidin is stained with AlexaFluor 594 (red); regions of
colocalization are yellow (B). The antibacterial effect induced by 1,25D3 was measured in medium from TERT-NHUC, 5637 and T24 bladder cells after
stimulation for 48 hours. E. coli CFT073 was incubated in conditioned medium from treated cells for 90 minutes (Supernatant). Cells from the same
experiment were harvested and lysed (Cell lysate). The resulting bacterial count is shown as percentage of vector treated control cells. Mean values
with standard deviation are shown from three independent experiments; ***P,0.001, **P,0.01 and *P,0.05 (ANOVA with Dunnett’s post-test) (C).
Adding a neutralizing anti-cathelicidin antibody (a-cathelicidin ab) to the conditioned medium from TERT-NHUC bladder cells blocked the
antibacterial effect, whereas conditioned medium in the presence of an irrelevant antibody maintained its antibacterial activity. Mean values with
standard deviation are shown from four independent experiments; *P,0.05 (ANOVA with Dunnett’s post-test) (D).
doi:10.1371/journal.pone.0015580.g006
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Uropathogenic E. coli strain CFT073 was isolated from a patient
with acute pyelonephritis and expresses type 1-, P- and S fimbriae
as well as alpha-hemolysin. Bacteria were grown overnight on
blood agar at 37uC, and then in LB broth for another 4 hours to
reach logarithmic phase of growth. Bacteria were harvested by
centrifugation and then washed twice with PBS. The bacterial
concentration was measured by spectrophotometry and confirmed
by viable count.
Bladder biopsy infection
Bladder biopsies were immediately transferred to serum-free
DMEM (Invitrogen) containing low-dose gentamicin (1 mg/mL)
with or without E. coli CFT073 at 10
8 CFU/mL and incubated at
37uC for 2 hours. Biopsies were then gently washed in PBS and
fixed in 4% paraformaldehyde (PFA) or homogenized for RNA
extraction using RNeasy Micro Kit (Qiagen) according to the
instructions from the manufacturer. Fixed tissue was embedded in
paraffin and sectioned at 4 mm.
Cells
TERT-NHUC, normal human telomerase-immortalized ur-
othelial cells were kindly provided by Prof M Knowles, University
of Leeds. These cells resemble normal urinary bladder cells to a
high degree [34]. Cells were maintained in Keratinocyte Serum-
Free Medium supplemented with bovine pituitary extract and
epidermal growth factor (Invitrogen). Normal human bladder
epithelium cells (HBEP) were obtained from CELLnTEC and
cultured in bladder epithelium medium (CnT-58, CELLnTEC).
All experiments with normal bladder cells were performed within
five passages. Urinary bladder cell lines T24 (ATCC No. HTB-4)
and 5637 (ATCC No. HTB-9) and kidney epithelial cell line A498
(ATCC No. HTB-44) were maintained in McCoy’s medium,
RPMI-1640 (Invitrogen) and Eagle’s MEM (Sigma-Aldrich)
respectively, supplemented with 10% fetal bovine serum (FBS).
Cell lines and HBEP were maintained in 5% CO2 and 80%
humidity at 37uC and 35uC respectively.
Cell experiments
Cell experiments were carried out in 6 or 24 well cell culture
plates (Costar), or Falcon Primaria tissue culture plates (BD
Falcon) for TERT-NHUC cells. When cells were near-confluent,
medium containing 2% charcoal treated FBS for T24 and 5637,
or fresh serum-free medium for TERT-NHUC cells and normal
bladder cells, was added, supplemented with 1,25D3 (a kind gift
from Dr. M. Uskokovic, BioXell), 25D3 (Calbiochem) or vector
alone (ethanol). 25D3 concentrations of 10
27 M were needed for a
consistent CAMP response in bladder cells whereas 1,25D3
concentrations of 10
28 M resulted in similar induction. All cell
experiments with vitamin D were performed away from direct
light.
RT- PCR
RNA was extracted using RNeasy Mini Kit (Qiagen) according
to instructions. Concentration and purity of RNA was determined
spectrophotometerically at 260 and 280 nm. An aliquot of 0.5–
1 mg of RNA was reversely transcribed using M-MuLV Reverse
Transcriptase (Finnzymes). Real-time PCR was performed on a
RotorGene 3000 (Corbett Research) with primers and probes
from Applied Biosystems; CAMP Hs00189038_m1, CYP24A1
Hs00167999_m1, CYP27B1 Hs00168017_m1, VDR Hs01045844_
m1. 18S rRNA was used as housekeeping gene. For relative
mRNA expression, fold change in gene expression was calculated
using the 2
2DDC
T method. Since CYP27B1, VDR and CYP24A1
are known to be expressed in the kidney epithelium, the kidney cell
line A498 was used as a positive control. mRNA expression in
bladder cells and tissue were therefore normalized to the levels in
A498.
Immunofluorescence confocal microscopy
Cells on cover-slips (VWR) were grown in the presence of 25D3,
1,25D3 or vector for 48 hours. For infection, 10
7 E. coli CFT073
per mL was added for 90 minutes. Cells were fixed in 4% PFA in
PBS. Antibodies and blocking sera were diluted in 0.1% Triton X-
100 in PBS. Unspecific antibody staining was blocked using 10%
rabbit serum (Sigma-Aldrich) for 60 minutes, followed by FX
Signal Enhancer (Invitrogen) for 30 minutes. Primary antibodies
used were: anti-cathelicidin monoclonal antibody 3D11 (HyCult
Technologies) 1:200 for 60 min, this antibody recognizes both the
pro-form (hCAP18) and the cleaved form (LL-37); anti-VDR
monoclonal antibody MA1-710 (Affinity BioReagents) 1:400 for
30 minutes, anti-CYP27B1 polyclonal antibody D-20 (Santa Cruz)
1:200 for 30 minutes and anti-CYP24A1 polyclonal antibody
(Sigman Aldrich) 1:150 for 30 minutes. Secondary antibodies
were: AlexaFluor 594-conjugated rabbit anti-mouse, anti-rat or
anti-goat antibody (Invitrogen) 1:400 for 30 minutes, or FITC-
conjugated anti-goat antibody (AbD Serotec) 1:600 for 30 minutes.
Nuclei were counterstained with DAPI (Invitrogen). Specificity of
immunolabelling was controlled in preparations without primary
antibody. Deparaffinized and rehydrated bladder sections were
stained as above, except primary antibody staining was carried out
at 4uC overnight. ProLong Gold antifade mounting medium
(Invitrogen) was used. Images were acquired with a Leica TCS
SP5 confocal microscope. Fluorescence intensity was quantified
using the ImageJ image processing software (U. S. National
Institutes of Health) [35]. For Live/Dead staining, cells were
infected with 10
7 E. coli CFT073 per mL for 60 minutes, washed to
remove unbound bacteria and incubated for an additional 60
minutes. Cells were permeabilized with 0.2% saponin in PBS for 5
minutes, before adding Live/Dead Bacterial Stain (Invitrogen) for
15 minutes. Cells were then mounted and analyzed by microscopy
immediately. For colocalization studies, GFP-labelled CFT073
strain LT004 (a kind gift from Prof Agneta Richter-Dahlfors,
Karolinska Institutet) was used [36].
Flow cytometry
Cells were exposed to 25D3, 1,25D3 or vector as described. After
detachment by trypsinization, they were washed in PBS, fixed and
permeabilized using the BD Cytofix/Cytoperm
TM Plus according
to instructions and stained with antibodies for 30–40 minutes at
4uC. Cells were stained with an anti-cathelicidin monoclonal
antibody 1-1C12 1:100 (HyCult Technologies) followed by an
AlexaFluor 488-conjugated anti-mouse IgG secondary antibody
(Invitrogen). The cells were analyzed on a Becton Dickinson
FACScalibur
TM flow cytometer using the CellQuest
TM software
(BD Biosciences Immunocytometry systems).
Antibacterial assay
After stimulation of bladder cells with 10
28 M 1,25D3 or vector
for 48 hours, 150 mL supernatant was incubated with 50 mlo f
10
4 CFU/mL E. coli CFT073 on a shaker at 37uC for 90 minutes.
An aliquot was plated on blood agar and colonies were counted
after incubation overnight. In selected experiments, 1 mg/mL anti-
cathelicidin monoclonal antibody 3D11 (HyCult Technologies) or
IgG1 isotype control (BD Biosciences) was added to the cell
supernatant for 120 minutes prior to bacterial coincubation. For
intracellular antibacterial assay, vitamin D-stimulated cells were
25D3 Induction of CAMP in the Urinary Bladder
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15580lysed in 1% Triton X-100 in PBS, centrifuged at 80006g for 5
minutes and used for antibacterial assay as described above.
Statistics
All statistical analyses were performed using GraphPad Prism
4.01. Mann-Whitney test, Wilcoxon rank test or ANOVA with
appropriate post test were used. Spearman rank test was used for
correlation between 25D3 and cathelicidin levels in serum. P-level
of less than 0.05 was considered significant.
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